Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis | 19 | 2024 | 2063 | 2.690 |
Why?
|
| Tuberculosis, Pulmonary | 11 | 2024 | 953 | 2.100 |
Why?
|
| Mycobacterium tuberculosis | 9 | 2024 | 1814 | 1.350 |
Why?
|
| Nucleic Acid Amplification Techniques | 3 | 2024 | 479 | 1.000 |
Why?
|
| Health Education | 4 | 2013 | 1544 | 0.720 |
Why?
|
| Lipopolysaccharides | 3 | 2024 | 2704 | 0.700 |
Why?
|
| Uganda | 11 | 2023 | 3092 | 0.700 |
Why?
|
| Social Networking | 3 | 2013 | 437 | 0.670 |
Why?
|
| Health Promotion | 4 | 2014 | 2751 | 0.540 |
Why?
|
| Epidemiological Monitoring | 1 | 2018 | 324 | 0.520 |
Why?
|
| Antitubercular Agents | 4 | 2024 | 1255 | 0.520 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 1 | 2016 | 62 | 0.510 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2017 | 541 | 0.510 |
Why?
|
| Carbapenems | 1 | 2016 | 110 | 0.500 |
Why?
|
| Feces | 1 | 2024 | 2075 | 0.500 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 474 | 0.460 |
Why?
|
| Antigens, Bacterial | 1 | 2020 | 1150 | 0.450 |
Why?
|
| Child Development | 2 | 2014 | 1845 | 0.440 |
Why?
|
| Homosexuality, Male | 5 | 2014 | 3378 | 0.430 |
Why?
|
| Rural Population | 4 | 2018 | 2230 | 0.430 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 2298 | 0.430 |
Why?
|
| Sputum | 5 | 2024 | 764 | 0.420 |
Why?
|
| HIV Infections | 14 | 2024 | 29762 | 0.400 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 421 | 0.400 |
Why?
|
| Men's Health | 1 | 2013 | 76 | 0.400 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2014 | 3290 | 0.390 |
Why?
|
| Seasons | 1 | 2019 | 1708 | 0.390 |
Why?
|
| Ambulatory Care Facilities | 2 | 2018 | 1432 | 0.370 |
Why?
|
| Cough | 2 | 2024 | 397 | 0.360 |
Why?
|
| Urbanization | 3 | 2015 | 85 | 0.360 |
Why?
|
| Contact Tracing | 1 | 2013 | 340 | 0.350 |
Why?
|
| Diarrhea | 2 | 2014 | 1288 | 0.340 |
Why?
|
| Bacteremia | 1 | 2018 | 1036 | 0.340 |
Why?
|
| Art | 1 | 2011 | 58 | 0.340 |
Why?
|
| Helicobacter Infections | 1 | 2014 | 429 | 0.340 |
Why?
|
| Child | 18 | 2024 | 68189 | 0.330 |
Why?
|
| Helicobacter pylori | 1 | 2014 | 503 | 0.320 |
Why?
|
| Biomass | 3 | 2015 | 353 | 0.320 |
Why?
|
| Latent Tuberculosis | 2 | 2022 | 247 | 0.310 |
Why?
|
| Influenza, Human | 1 | 2019 | 1456 | 0.300 |
Why?
|
| Hepatitis B, Chronic | 2 | 2024 | 574 | 0.300 |
Why?
|
| Problem-Based Learning | 1 | 2011 | 386 | 0.300 |
Why?
|
| Health Status Indicators | 1 | 2013 | 951 | 0.290 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2203 | 0.290 |
Why?
|
| Peru | 5 | 2020 | 606 | 0.290 |
Why?
|
| Sensitivity and Specificity | 8 | 2024 | 15784 | 0.280 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 1761 | 0.280 |
Why?
|
| Poverty | 2 | 2018 | 2770 | 0.280 |
Why?
|
| Child, Preschool | 12 | 2024 | 35739 | 0.270 |
Why?
|
| Triage | 2 | 2024 | 953 | 0.270 |
Why?
|
| Malnutrition | 1 | 2012 | 491 | 0.270 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2013 | 3947 | 0.270 |
Why?
|
| Schools | 1 | 2014 | 1450 | 0.260 |
Why?
|
| Adolescent | 19 | 2024 | 85585 | 0.250 |
Why?
|
| Students | 2 | 2014 | 2264 | 0.250 |
Why?
|
| Anemia | 1 | 2014 | 1355 | 0.240 |
Why?
|
| Prevalence | 10 | 2024 | 16603 | 0.240 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1566 | 0.230 |
Why?
|
| Primary Health Care | 2 | 2018 | 5339 | 0.220 |
Why?
|
| Social Stigma | 1 | 2013 | 1283 | 0.220 |
Why?
|
| Social Media | 2 | 2014 | 1170 | 0.210 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 37 | 0.210 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 4295 | 0.210 |
Why?
|
| Residence Characteristics | 1 | 2015 | 2886 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2013 | 5701 | 0.200 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 2235 | 0.190 |
Why?
|
| Humans | 47 | 2024 | 725992 | 0.190 |
Why?
|
| Peer Group | 3 | 2013 | 1184 | 0.180 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 2364 | 0.170 |
Why?
|
| Anti-HIV Agents | 2 | 2020 | 6342 | 0.170 |
Why?
|
| Internet | 1 | 2013 | 3417 | 0.170 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2019 | 322 | 0.170 |
Why?
|
| Male | 29 | 2024 | 372843 | 0.160 |
Why?
|
| Data Accuracy | 1 | 2021 | 193 | 0.160 |
Why?
|
| Public Policy | 1 | 2023 | 619 | 0.160 |
Why?
|
| Fetal Blood | 1 | 2023 | 961 | 0.150 |
Why?
|
| Immunoassay | 2 | 2020 | 961 | 0.150 |
Why?
|
| Rain | 1 | 2019 | 148 | 0.150 |
Why?
|
| Adult | 20 | 2024 | 212289 | 0.150 |
Why?
|
| Poisson Distribution | 1 | 2019 | 423 | 0.150 |
Why?
|
| Blood Culture | 1 | 2018 | 73 | 0.140 |
Why?
|
| Spirometry | 3 | 2015 | 743 | 0.140 |
Why?
|
| Sexual Behavior | 1 | 2011 | 4297 | 0.140 |
Why?
|
| Serologic Tests | 1 | 2020 | 559 | 0.140 |
Why?
|
| Cognition Disorders | 1 | 2014 | 7043 | 0.140 |
Why?
|
| Thailand | 1 | 2018 | 469 | 0.130 |
Why?
|
| Sleep Deprivation | 2 | 2012 | 562 | 0.130 |
Why?
|
| Incidence | 4 | 2023 | 16604 | 0.130 |
Why?
|
| Social Class | 2 | 2018 | 2167 | 0.130 |
Why?
|
| Income | 1 | 2023 | 1490 | 0.130 |
Why?
|
| Feasibility Studies | 3 | 2013 | 5677 | 0.130 |
Why?
|
| Peptide Hydrolases | 1 | 2021 | 810 | 0.130 |
Why?
|
| Urban Population | 3 | 2018 | 2014 | 0.130 |
Why?
|
| Infant | 6 | 2019 | 29781 | 0.120 |
Why?
|
| Female | 22 | 2024 | 391083 | 0.120 |
Why?
|
| Pediatrics | 2 | 2019 | 2634 | 0.120 |
Why?
|
| Fossil Fuels | 1 | 2015 | 32 | 0.120 |
Why?
|
| Bronchitis, Chronic | 1 | 2015 | 53 | 0.120 |
Why?
|
| Social Work | 1 | 2018 | 345 | 0.120 |
Why?
|
| Consensus | 1 | 2024 | 3041 | 0.120 |
Why?
|
| Protozoan Vaccines | 1 | 2014 | 49 | 0.110 |
Why?
|
| Cognition | 1 | 2014 | 10259 | 0.110 |
Why?
|
| Infant, Newborn | 5 | 2022 | 22661 | 0.110 |
Why?
|
| beta-Lactamases | 1 | 2016 | 301 | 0.110 |
Why?
|
| Suburban Population | 1 | 2014 | 50 | 0.110 |
Why?
|
| Cell Wall | 1 | 2016 | 443 | 0.110 |
Why?
|
| Age Factors | 4 | 2023 | 17598 | 0.110 |
Why?
|
| Rural Health | 1 | 2015 | 277 | 0.110 |
Why?
|
| World Health Organization | 1 | 2017 | 809 | 0.110 |
Why?
|
| Cryptosporidiosis | 1 | 2014 | 138 | 0.110 |
Why?
|
| Zimbabwe | 1 | 2014 | 298 | 0.100 |
Why?
|
| Antiprotozoal Agents | 1 | 2014 | 214 | 0.100 |
Why?
|
| Urban Health | 1 | 2015 | 484 | 0.100 |
Why?
|
| Employment | 1 | 2018 | 959 | 0.100 |
Why?
|
| Vital Capacity | 1 | 2015 | 949 | 0.100 |
Why?
|
| Malawi | 1 | 2013 | 421 | 0.090 |
Why?
|
| Smoke | 1 | 2015 | 505 | 0.090 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1296 | 0.090 |
Why?
|
| Temperature | 1 | 2019 | 3044 | 0.090 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 465 | 0.090 |
Why?
|
| Altitude | 1 | 2015 | 501 | 0.090 |
Why?
|
| Breath Tests | 1 | 2014 | 546 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 7584 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2023 | 8798 | 0.080 |
Why?
|
| Young Adult | 7 | 2024 | 62272 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 492 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 1033 | 0.080 |
Why?
|
| Ghana | 1 | 2011 | 295 | 0.080 |
Why?
|
| Genomics | 2 | 2017 | 5242 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2019 | 6169 | 0.080 |
Why?
|
| Risk Factors | 7 | 2023 | 59050 | 0.080 |
Why?
|
| Delphi Technique | 2 | 2024 | 937 | 0.080 |
Why?
|
| Urea | 1 | 2014 | 804 | 0.080 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 705 | 0.080 |
Why?
|
| Proteomics | 1 | 2021 | 3666 | 0.070 |
Why?
|
| Second Messenger Systems | 1 | 2009 | 309 | 0.070 |
Why?
|
| Smoking | 2 | 2015 | 7599 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2023 | 19200 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 21058 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2018 | 19067 | 0.070 |
Why?
|
| Unsafe Sex | 1 | 2013 | 1066 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2021 | 41936 | 0.070 |
Why?
|
| Hospitals | 1 | 2018 | 2710 | 0.060 |
Why?
|
| Culture | 1 | 2011 | 742 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 16874 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2023 | 6246 | 0.060 |
Why?
|
| Global Health | 2 | 2014 | 2532 | 0.060 |
Why?
|
| Goals | 1 | 2011 | 732 | 0.060 |
Why?
|
| Universities | 1 | 2013 | 1667 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 8360 | 0.060 |
Why?
|
| Coinfection | 2 | 2024 | 1004 | 0.060 |
Why?
|
| Middle Aged | 9 | 2024 | 208873 | 0.060 |
Why?
|
| Social Support | 2 | 2014 | 3317 | 0.060 |
Why?
|
| Hospitalization | 2 | 2019 | 8096 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 1948 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2015 | 1982 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 12390 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 29214 | 0.050 |
Why?
|
| Aged | 5 | 2024 | 160396 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2009 | 2039 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1763 | 0.050 |
Why?
|
| Hippocampus | 2 | 2012 | 8873 | 0.050 |
Why?
|
| Standard of Care | 1 | 2023 | 312 | 0.040 |
Why?
|
| Guinea-Bissau | 1 | 2020 | 15 | 0.040 |
Why?
|
| Venezuela | 1 | 2020 | 33 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58168 | 0.040 |
Why?
|
| Digestion | 1 | 2021 | 108 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2019 | 76373 | 0.040 |
Why?
|
| Immunologic Tests | 1 | 2020 | 79 | 0.040 |
Why?
|
| United States | 3 | 2020 | 67016 | 0.040 |
Why?
|
| Sex Factors | 1 | 2014 | 10374 | 0.040 |
Why?
|
| South Africa | 1 | 2023 | 1173 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2014 | 3496 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 14533 | 0.040 |
Why?
|
| Rifampin | 1 | 2022 | 518 | 0.040 |
Why?
|
| Asthma | 1 | 2015 | 4751 | 0.040 |
Why?
|
| Child Nutrition Disorders | 1 | 2019 | 75 | 0.040 |
Why?
|
| Diet | 1 | 2012 | 4643 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2024 | 1208 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2022 | 869 | 0.040 |
Why?
|
| Animals | 5 | 2016 | 227777 | 0.040 |
Why?
|
| Time Factors | 3 | 2014 | 40000 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2019 | 1146 | 0.030 |
Why?
|
| Lung | 1 | 2015 | 10283 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 23101 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 30142 | 0.030 |
Why?
|
| California | 2 | 2024 | 23655 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 25703 | 0.030 |
Why?
|
| Epitopes | 1 | 2020 | 2179 | 0.030 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 944 | 0.030 |
Why?
|
| Linear Models | 1 | 2023 | 5330 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2014 | 32435 | 0.030 |
Why?
|
| Pregnancy | 1 | 2014 | 29867 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1136 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2410 | 0.020 |
Why?
|
| Proteome | 1 | 2021 | 1927 | 0.020 |
Why?
|
| HIV | 1 | 2021 | 2544 | 0.020 |
Why?
|
| Rolipram | 1 | 2009 | 56 | 0.020 |
Why?
|
| Gene Expression | 1 | 2023 | 9185 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 130 | 0.020 |
Why?
|
| Colforsin | 1 | 2009 | 396 | 0.020 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2009 | 73 | 0.020 |
Why?
|
| Registries | 1 | 2024 | 8105 | 0.020 |
Why?
|
| Memory | 2 | 2012 | 3860 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 1086 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2024 | 62040 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 9267 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2018 | 4728 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2009 | 855 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2397 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 1891 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 1199 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 4557 | 0.010 |
Why?
|
| Biomarkers | 1 | 2023 | 21566 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 25180 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 12241 | 0.010 |
Why?
|
| Insulin | 1 | 2012 | 5645 | 0.010 |
Why?
|
| Computational Biology | 1 | 2012 | 4445 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 2796 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 24212 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 13898 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 92660 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 28035 | 0.000 |
Why?
|